DOI QR코드

DOI QR Code

Remissions of Crohn's Disease at Onset and Relapse Using Herbal Medicine: A Case Report

발병과 재발에 한약으로 관해가 유도된 크론병 증례 보고

  • Lee, Byung-Hee (Hanstep Korean Medicine Clinic) ;
  • Won, Jiyoon (Department of Korean Medical Science, Graduate School, Kyung Hee University) ;
  • Park, Jae Rang (Acupuncture and Meridian Science Research Center, Kyung Hee University) ;
  • Lee, Hyangsook (Department of Korean Medical Science, Graduate School, Kyung Hee University)
  • 이병희 (한걸음한의원) ;
  • 원지윤 (경희대학교 한의과대학 대학원 기초한의과학과) ;
  • 박재량 (경희대학교 침구경락융합연구센터) ;
  • 이향숙 (경희대학교 한의과대학 대학원 기초한의과학과)
  • Received : 2020.08.18
  • Accepted : 2020.09.11
  • Published : 2020.09.27

Abstract

This case report details two remissions at onset and relapse after 4 years each with Korean herbal medicine treatment in a 33-year-old male patient diagnosed as Crohn's disease (CD) by clinical and colonoscopic examination. He presented bloody diarrhea and severe abdominal pain, and his symptoms were persistent even with usual Western medications, so he was offered surgery and biologics. He was then given Sayeok-Tang for 8 months and remission was induced. Four years later he had a relapse and this time he was given Banha-Sasim-Tang, and Baekduong-Ga-Gamcho-Agyo-Tang, based on pattern changes with intense symptom monitoring. Clinical and endoscopic remission was confirmed after 4 months of herbal medicine treatment and no adverse events were reported. This case report shows that individualized Korean herbal medicine treatment has the potential for induction of remission of CD and further research is warranted.

Keywords

References

  1. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990 ; 335(8697) : 1078-80. https://doi.org/10.1016/0140-6736(90)92643-V
  2. Song IS. Inflammatory bowel disease in Korea. Korean J Med. 1999 ; 57(4) : 661-75.
  3. Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, et al. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol. 2019 ; 34(6) : 1018-26. https://doi.org/10.1111/jgh.14542
  4. Wehkamp J, Gotz M, Herrlinger K, Steurer W, Stange EF. Inflammatory Bowel Disease. Dtsch Arztebl Int. 2016 ; 113(5) : 72-82. https://doi.org/10.3238/arztebl.2016.0072
  5. Papamichael K, Lin S, Moore M, Papaioannou G, Sattler L, Cheifetz AS. Infliximab in inflammatory bowel disease. Ther Adv Chronic Dis. 2019 ; 10 : 2040622319838443. https://doi.org/10.1177/2040622319838443
  6. Bots S, Gecse K, Barclay M, D'Haens G. Combination Immunosuppression in IBD. Inflamm Bowel Dis. 2018 ; 24(3) : 539-45. https://doi.org/10.1093/ibd/izx065
  7. Kim SW, Lee OJ, Shin JC. Case report :A Case Study of a Crohn's Disease Patient Treated with Oriental Medical Treatment. Korean J Acupunct. 2014 ; 31(4) : 247-52. https://doi.org/10.14406/acu.2014.035
  8. Na WG, Yang MR, Lee HJ, Park EJ. A case report of Crohn’s disease. J Korean Oriental Pediatrics. 2002 ; 16(2) : 51-8.
  9. Seo SH, Jeong JO, Lee EJ, Choi IS, Park SE, Kim WI, et al. A Case Study of Suspected Crohn’s Disease Treated with Bojanggunbitang. Korean J Orient Int Med. 2004 ; 25(3) : 648-54.
  10. Lee MS, Hwang MW, Kim YH. A Case Study of a Soyangin Patient with Crohn's Disease who Reported Symptomatic Improvement after Being Treated with Dojeokgangki-tang. J of Sasang Constitutional Medicine. 2012 ; 24(2) : 61-70. https://doi.org/10.7730/jscm.2012.24.2.061
  11. Park JM, Kim HJ, Keum DH, Park YH, Lee MJ. The effect of Oriental Medical Treatment on Crohn’s disease; 1 Case Report. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves. 2010 ; 5(1) : 57-66.
  12. Lee BH, Won J, Lee H. Herbal Medicine Treatment for Induction and Maintenance of Remission in Ulcerative Colitis: A Case Report. Korean J Acupunct. 2019 ; 36(3) : 181-7. https://doi.org/10.14406/acu.2019.014
  13. Kono T, Satomi M, Chisato N, Ebisawa Y, Suno M, Asama T, et al. Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis. World J Oncol. 2010 ; 1(6) : 232-5. https://doi.org/10.4021/wjon263w
  14. Nikkhah-Bodaghi M, Maleki I, Agah S, Hekmatdoost A. Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial. Complement Ther Med. 2019 ; 43 : 1-6. https://doi.org/10.1016/j.ctim.2018.12.021
  15. Kil TC, Kwon KR. The Bibilographic studies on Aconiti Ciliare Tuber and Radix Aconiti. J Pharmacopuncture. 2001 ; 4(2): 87-93. https://doi.org/10.3831/kpi.2001.4.2.087
  16. Moriyama S, Hinode D, Yoshioka M, Sogawa Y, Nishino T, Tangoku A, et al. Impact of the use of Kampo medicine in patients with esophageal cancer during chemotherapy:a clinical trial for oral hygiene and oral condition. J Med Invest. 2018 ; 65(3.4) : 184-90. https://doi.org/10.2152/jmi.65.184
  17. Lee IA, Hyun YJ, Kim DH. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-kappaB activation. Eur J Pharmacol. 2010 ; 648(1-3) : 162-70. https://doi.org/10.1016/j.ejphar.2010.08.046
  18. Chen Z, Guan Y, Zhou L, Xu Y, Yang M, Liu H. Preparation and characterization of colon-targeted particles of Pulsatilla chinensis saponins. Nat Prod Commun. 2015 ; 10(2) : 237-8. https://doi.org/10.1177/1934578x1501000204
  19. Wu L, Li X, Wu H, Long W, Jiang X, Shen T, et al. 5-Methoxyl Aesculetin Abrogates Lipopolysaccharide-Induced Inflammation by Suppressing MAPK and AP-1 Pathways in RAW 264.7 Cells. Int J Mol Sci. 2016 ; 17(3) : 315. https://doi.org/10.3390/ijms17030315
  20. Wu H, Yang F, Cui S, Qin Y, Liu J, Zhang Y. Hematopoietic effect of fractions from the enzyme-digested colla corii asini on mice with 5-fluorouracil induced anemia. Am J Chin Med. 2007 ; 35(5) : 853-66. https://doi.org/10.1142/s0192415x07005326
  21. Hitomi S, Ujihara I, Ono K. Pain mechanism of oral ulcerative mucositis and the therapeutic traditional herbal medicine hangeshashinto. J Oral Biosci. 2019 ; 61(1) : 12-5. https://doi.org/10.1016/j.job.2019.01.004